Risk Factors Associated with Relapse in Major Depressive Disorder in Primary Care Patients: A Systematic Review

Maider Prieto-Vila1, Francisco J Estupiñá, Antonio Cano-Vindel

  • 1Universidad Complutense de Madrid.

Psicothema
|January 17, 2021
PubMed
Abstract

Insights

Identifying risk factors for Major Depressive Disorder (MDD) relapse in primary care is crucial. Factors like neuroticism, low self-esteem, and poor adherence to antidepressant medication increase relapse risk.

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Primary Care Medicine

Background:

  • Major Depressive Disorder (MDD) is characterized by high recurrence rates.
  • The majority of MDD patients receive treatment within the Primary Care (PC) setting.
  • Understanding relapse predictors in PC is essential for effective long-term management.

Purpose of the Study:

  • To systematically identify risk factors associated with the relapse of Major Depressive Disorder (MDD) in primary care settings.
  • To synthesize evidence from existing literature to inform clinical practice and future research.
  • To provide a comprehensive overview of factors influencing MDD recurrence.

Main Methods:

  • A systematic review was conducted adhering to PRISMA guidelines.
  • Literature searches were performed across major databases: PsycINFO, PubMed, Web of Science, and ScienceDirect.
  • Studies published between 1978 and 2019 were included.

Main Results:

  • Twelve distinct risk factors for MDD relapse were identified across eight eligible studies.
  • Higher relapse frequency was associated with increased neuroticism, disability, episode severity, childhood abuse, and comorbidity.
  • Lower relapse risk was linked to higher extraversion, self-esteem, emotional/physical functioning, and better adherence to antidepressant medication (ADM).
  • Combination treatments (ADM with CBT/psychoeducation) and mindfulness-based cognitive therapy showed promise in reducing relapse.

Conclusions:

  • Several risk factors for MDD relapse in primary care have been identified, despite study heterogeneity.
  • Further research, particularly randomized controlled trials, is necessary to solidify these findings and guide interventions.
  • Targeting identified risk factors and optimizing treatment strategies are key to reducing MDD recurrence.

Related Concept Videos

Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
310
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
278
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
338
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
574
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
607
Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
4.8K